(ONTO) Onto Innovation - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US6833441057
Stock: Metrology, Inspection, Lithography, Software, Services
Total Rating 43
Risk 99
Buy Signal 1.28
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 63.4% |
| Relative Tail Risk | -9.28% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.28 |
| Alpha | -30.93 |
| Character TTM | |
|---|---|
| Beta | 2.275 |
| Beta Downside | 1.877 |
| Drawdowns 3y | |
|---|---|
| Max DD | 62.82% |
| CAGR/Max DD | 0.60 |
Description: ONTO Onto Innovation January 08, 2026
Onto Innovation Inc. (NYSE: ONTO) designs, develops, manufactures, and supports optical metrology and inspection tools for process control across the semiconductor and advanced-packaging supply chain. Its portfolio spans lithography systems, macro-defect inspection, thin-film measurement equipment, and a suite of process-control software that can be deployed on single tools, tool groups, or enterprise-wide factories.
Key performance indicators from the most recent filing show FY 2023 revenue of roughly $1.2 billion, with a gross margin of 45% and R&D spending around 12% of revenue-metrics that align with industry averages for semiconductor equipment firms.
The company’s market outlook is heavily influenced by the broader semiconductor equipment sector, which is projected to grow at a 5-6% compound annual growth rate through 2028, driven by expanding wafer-fab capacity, the shift toward advanced packaging, and sustained demand for high-performance logic and memory chips.
For deeper insight, consider exploring ValueRay’s analytical platform.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 175.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 1.27 > 1.0 |
| NWC/Revenue: 137.9% < 20% (prev 139.4%; Δ -1.49% < -1%) |
| CFO/TA 0.13 > 3% & CFO 289.3m > Net Income 175.0m |
| Net Debt (-589.0m) to EBITDA (229.6m): -2.57 < 3 |
| Current Ratio: 9.49 > 1.5 & < 3 |
| Outstanding Shares: last quarter (49.1m) vs 12m ago -1.18% < -2% |
| Gross Margin: 50.72% > 18% (prev 0.52%; Δ 5020 % > 0.5%) |
| Asset Turnover: 47.06% > 50% (prev 45.44%; Δ 1.61% > 0%) |
| Interest Coverage Ratio: -9.46 > 6 (EBITDA TTM 229.6m / Interest Expense TTM -18.6m) |
Altman Z'' 9.93
| A: 0.63 (Total Current Assets 1.54b - Total Current Liabilities 162.9m) / Total Assets 2.19b |
| B: 0.34 (Retained Earnings 733.3m / Total Assets 2.19b) |
| C: 0.08 (EBIT TTM 176.0m / Avg Total Assets 2.13b) |
| D: 3.94 (Book Value of Equity 726.9m / Total Liabilities 184.5m) |
| Altman-Z'' Score: 9.93 = AAA |
Beneish M -3.05
| DSRI: 0.96 (Receivables 260.2m/253.7m, Revenue 1.00b/942.2m) |
| GMI: 1.03 (GM 50.72% / 52.10%) |
| AQI: 0.99 (AQ_t 0.23 / AQ_t-1 0.23) |
| SGI: 1.06 (Revenue 1.00b / 942.2m) |
| TATA: -0.05 (NI 175.0m - CFO 289.3m) / TA 2.19b) |
| Beneish M-Score: -3.05 (Cap -4..+1) = AA |
What is the price of ONTO shares?
As of February 08, 2026, the stock is trading at USD 208.50 with a total of 973,251 shares traded.
Over the past week, the price has changed by +3.19%, over one month by +11.34%, over three months by +58.25% and over the past year by -0.99%.
Over the past week, the price has changed by +3.19%, over one month by +11.34%, over three months by +58.25% and over the past year by -0.99%.
Is ONTO a buy, sell or hold?
Onto Innovation has received a consensus analysts rating of 4.11.
Therefore, it is recommended to buy ONTO.
- StrongBuy: 4
- Buy: 2
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ONTO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 208.1 | -0.2% |
| Analysts Target Price | 208.1 | -0.2% |
| ValueRay Target Price | 256.5 | 23% |
ONTO Fundamental Data Overview February 07, 2026
P/E Trailing = 53.2
P/E Forward = 29.4118
P/S = 9.3556
P/B = 4.6774
P/EG = 0.98
Revenue TTM = 1.00b USD
EBIT TTM = 176.0m USD
EBITDA TTM = 229.6m USD
Long Term Debt = 14.1m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 5.62m USD (from shortTermDebt, last quarter)
Debt = 14.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -589.0m USD (from netDebt column, last quarter)
Enterprise Value = 8.41b USD (9.38b + Debt 14.1m - CCE 983.9m)
Interest Coverage Ratio = -9.46 (Ebit TTM 176.0m / Interest Expense TTM -18.6m)
EV/FCF = 32.18x (Enterprise Value 8.41b / FCF TTM 261.3m)
FCF Yield = 3.11% (FCF TTM 261.3m / Enterprise Value 8.41b)
FCF Margin = 26.07% (FCF TTM 261.3m / Revenue TTM 1.00b)
Net Margin = 17.46% (Net Income TTM 175.0m / Revenue TTM 1.00b)
Gross Margin = 50.72% ((Revenue TTM 1.00b - Cost of Revenue TTM 493.9m) / Revenue TTM)
Gross Margin QoQ = 50.70% (prev 48.16%)
Tobins Q-Ratio = 3.85 (Enterprise Value 8.41b / Total Assets 2.19b)
Interest Expense / Debt = 22.51% (Interest Expense 3.17m / Debt 14.1m)
Taxrate = 11.74% (3.75m / 32.0m)
NOPAT = 155.4m (EBIT 176.0m * (1 - 11.74%))
Current Ratio = 9.49 (Total Current Assets 1.54b / Total Current Liabilities 162.9m)
Debt / Equity = 0.01 (Debt 14.1m / totalStockholderEquity, last quarter 2.00b)
Debt / EBITDA = -2.57 (Net Debt -589.0m / EBITDA 229.6m)
Debt / FCF = -2.25 (Net Debt -589.0m / FCF TTM 261.3m)
Total Stockholder Equity = 1.95b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.22% (Net Income 175.0m / Total Assets 2.19b)
RoE = 8.96% (Net Income TTM 175.0m / Total Stockholder Equity 1.95b)
RoCE = 8.95% (EBIT 176.0m / Capital Employed (Equity 1.95b + L.T.Debt 14.1m))
RoIC = 7.96% (NOPAT 155.4m / Invested Capital 1.95b)
WACC = 14.31% (E(9.38b)/V(9.39b) * Re(14.30%) + D(14.1m)/V(9.39b) * Rd(22.51%) * (1-Tc(0.12)))
Discount Rate = 14.30% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.46%
[DCF Debug] Terminal Value 63.45% ; FCFF base≈245.4m ; Y1≈302.7m ; Y5≈515.5m
Fair Price DCF = 87.50 (EV 3.76b - Net Debt -589.0m = Equity 4.34b / Shares 49.7m; r=14.31% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -35.66 | EPS CAGR: -47.69% | SUE: -4.0 | # QB: 0
Revenue Correlation: 16.55 | Revenue CAGR: -0.89% | SUE: -0.45 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.27 | Chg30d=+0.022 | Revisions Net=+3 | Analysts=8
EPS next Year (2026-12-31): EPS=6.19 | Chg30d=+0.114 | Revisions Net=+5 | Growth EPS=+24.9% | Growth Revenue=+18.7%
P/E Forward = 29.4118
P/S = 9.3556
P/B = 4.6774
P/EG = 0.98
Revenue TTM = 1.00b USD
EBIT TTM = 176.0m USD
EBITDA TTM = 229.6m USD
Long Term Debt = 14.1m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 5.62m USD (from shortTermDebt, last quarter)
Debt = 14.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -589.0m USD (from netDebt column, last quarter)
Enterprise Value = 8.41b USD (9.38b + Debt 14.1m - CCE 983.9m)
Interest Coverage Ratio = -9.46 (Ebit TTM 176.0m / Interest Expense TTM -18.6m)
EV/FCF = 32.18x (Enterprise Value 8.41b / FCF TTM 261.3m)
FCF Yield = 3.11% (FCF TTM 261.3m / Enterprise Value 8.41b)
FCF Margin = 26.07% (FCF TTM 261.3m / Revenue TTM 1.00b)
Net Margin = 17.46% (Net Income TTM 175.0m / Revenue TTM 1.00b)
Gross Margin = 50.72% ((Revenue TTM 1.00b - Cost of Revenue TTM 493.9m) / Revenue TTM)
Gross Margin QoQ = 50.70% (prev 48.16%)
Tobins Q-Ratio = 3.85 (Enterprise Value 8.41b / Total Assets 2.19b)
Interest Expense / Debt = 22.51% (Interest Expense 3.17m / Debt 14.1m)
Taxrate = 11.74% (3.75m / 32.0m)
NOPAT = 155.4m (EBIT 176.0m * (1 - 11.74%))
Current Ratio = 9.49 (Total Current Assets 1.54b / Total Current Liabilities 162.9m)
Debt / Equity = 0.01 (Debt 14.1m / totalStockholderEquity, last quarter 2.00b)
Debt / EBITDA = -2.57 (Net Debt -589.0m / EBITDA 229.6m)
Debt / FCF = -2.25 (Net Debt -589.0m / FCF TTM 261.3m)
Total Stockholder Equity = 1.95b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.22% (Net Income 175.0m / Total Assets 2.19b)
RoE = 8.96% (Net Income TTM 175.0m / Total Stockholder Equity 1.95b)
RoCE = 8.95% (EBIT 176.0m / Capital Employed (Equity 1.95b + L.T.Debt 14.1m))
RoIC = 7.96% (NOPAT 155.4m / Invested Capital 1.95b)
WACC = 14.31% (E(9.38b)/V(9.39b) * Re(14.30%) + D(14.1m)/V(9.39b) * Rd(22.51%) * (1-Tc(0.12)))
Discount Rate = 14.30% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.46%
[DCF Debug] Terminal Value 63.45% ; FCFF base≈245.4m ; Y1≈302.7m ; Y5≈515.5m
Fair Price DCF = 87.50 (EV 3.76b - Net Debt -589.0m = Equity 4.34b / Shares 49.7m; r=14.31% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -35.66 | EPS CAGR: -47.69% | SUE: -4.0 | # QB: 0
Revenue Correlation: 16.55 | Revenue CAGR: -0.89% | SUE: -0.45 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.27 | Chg30d=+0.022 | Revisions Net=+3 | Analysts=8
EPS next Year (2026-12-31): EPS=6.19 | Chg30d=+0.114 | Revisions Net=+5 | Growth EPS=+24.9% | Growth Revenue=+18.7%